FDA has announced that it will review the safety of oral contraceptives (OCs) containing the progestin drospirenone after 2 recent studies in the British Medical Journal (2011;340:d2139 and 2011;340:d2151) suggested that they might cause more blood clots than birth control pills containing levonorgestrel.
FDA has announced that it will review the safety of oral contraceptives (OCs) containing the progestin drospirenone after 2 recent studies in the British Medical Journal (2011;340:d2139 and 2011;340:d2151) suggested that they might cause more blood clots than birth control pills containing levonorgestrel.
The studies reported a 2- to 3-fold higher risk of venous thromboembolic events (including deep vein thrombosis and pulmonary embolism) among women using OCs with drospirenone compared with levonorgestrel. Previous studies of blood clots associated with drospirenone produced conflicting findings. FDA has commissioned an 800,000-person study to examine the risks of drospirenone OCs and expects to have results later this year.
Drospirenone is found in OCs marketed under the brand names Beyaz, Safyral, Yaz (generics Gianvi and Loryna), and Yasmin (generics Ocella, Syeda, and Zarah). In addition to contraception, the pills are used to treat moderate acne and premenstrual dysphoric disorder, and to increase folate levels in women using oral contraceptives for birth control.
Long-term mortality risks for women with adverse pregnancy outcomes
April 19th 2024A recent study revealed that women who experience major adverse pregnancy outcomes face heightened long-term mortality risks, shedding light on the need for comprehensive understanding and preventative measures in women's health.
Read More
Unlocking placenta accreta spectrum with single-cell gene targets
April 18th 2024Discover how cutting-edge single-cell RNA sequencing unveils molecular insights into placenta accreta spectrum disorders, potentially revolutionizing diagnostics and treatments for this life-threatening pregnancy complication.
Read More
Genetics associated with reproductive traits and uterine leiomyomata
April 17th 2024Investigating genetic correlations and shared loci sheds light on potential causal relationships between reproductive traits and uterine leiomyomata, offering insights into their complex interplay and urging further mechanistic exploration.
Read More